Lazard Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-183,991
| Closed | -$2.51M | – | 2325 |
|
|
2024
Q1 | $2.51M | Hold |
183,991
| – | – | ﹤0.01% | 802 |
|
|
2023
Q4 | $2.48M | Hold |
183,991
| – | – | ﹤0.01% | 811 |
|
|
2023
Q3 | $2.29M | Sell |
183,991
-1,341
| -0.7% | -$16.7K | ﹤0.01% | 850 |
|
|
2023
Q2 | $2.51M | Hold |
185,332
| – | – | ﹤0.01% | 847 |
|
|
2023
Q1 | $2.58M | Hold |
185,332
| – | – | ﹤0.01% | 868 |
|
|
2022
Q4 | $2.63M | Hold |
185,332
| – | – | ﹤0.01% | 861 |
|
|
2022
Q3 | $2.53M | Hold |
185,332
| – | – | ﹤0.01% | 835 |
|
|
2022
Q2 | $2.64M | Hold |
185,332
| – | – | ﹤0.01% | 853 |
|
|
2022
Q1 | $3.07M | Hold |
185,332
| – | – | ﹤0.01% | 828 |
|
|
2021
Q4 | $3.56M | Hold |
185,332
| – | – | ﹤0.01% | 838 |
|
|
2021
Q3 | $3.85M | Sell |
185,332
-19,130
| -9% | -$398K | ﹤0.01% | 813 |
|
|
2021
Q2 | $4.38M | Hold |
204,462
| – | – | ﹤0.01% | 741 |
|
|
2021
Q1 | $4.03M | Hold |
204,462
| – | – | ﹤0.01% | 698 |
|
|
2020
Q4 | $4.04M | Hold |
204,462
| – | – | 0.01% | 684 |
|
|
2020
Q3 | $3.59M | Buy |
204,462
+11,892
| +6% | +$209K | 0.01% | 651 |
|
|
2020
Q2 | $3.46M | Buy |
192,570
+148,525
| +337% | +$2.67M | 0.01% | 615 |
|
|
2020
Q1 | $659K | Buy |
+44,045
| New | +$659K | ﹤0.01% | 781 |
|
|
2014
Q1 | – | Sell |
-149,729
| Closed | -$3.06M | – | 1034 |
|
|
2013
Q4 | $3.06M | Hold |
149,729
| – | – | 0.01% | 573 |
|
|
2013
Q3 | $2.89M | Sell |
149,729
-887
| -0.6% | -$17.1K | 0.01% | 569 |
|
|
2013
Q2 | $2.68M | Buy |
+150,616
| New | +$2.68M | 0.01% | 594 |
|